Meeting report: 34th international conference on antiviral research

Andrea Brancale; Kara Carter; Leen Delang; Jerome Deval; David Durantel; Brian G. Gentry; Robert Jordan; Justin G. Julander; Michael K. Lo; Maria Jesús Pérez-Pérez; Luis M. Schang; Katherine L. Seley-Radtke; Pei Yong Shi; Subhash G. Vasudevan; Richard J. Whitley; Jessica R. Spengler

doi:10.1177/20402066221130853

Meeting report: 34th international conference on antiviral research

Andrea Brancale, Kara Carter, Leen Delang, Jerome Deval, David Durantel, Brian G. Gentry, Robert Jordan, Justin G. Julander, Michael K. Lo, Maria Jesús Pérez-Pérez, Luis M. Schang, Katherine L. Seley-Radtke, Pei Yong Shi, Subhash G. Vasudevan, Richard J. Whitley, Jessica R. Spengler

Biochemistry & Molecular Biology

Research output: Contribution to journal › Article › peer-review

Abstract

As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.

Original language	English (US)
Journal	Antiviral Chemistry and Chemotherapy
Volume	30
DOIs	https://doi.org/10.1177/20402066221130853
State	Published - 2022

Keywords

ICAR
ISAR meeting
Virus
antiviral
therapeutics
vaccines

ASJC Scopus subject areas

Pharmacology
Drug Discovery
Virology

Access to Document

10.1177/20402066221130853

Cite this

Brancale, A., Carter, K., Delang, L., Deval, J., Durantel, D., Gentry, B. G., Jordan, R., Julander, J. G., Lo, M. K., Pérez-Pérez, M. J., Schang, L. M., Seley-Radtke, K. L., Shi, P. Y., Vasudevan, S. G., Whitley, R. J., & Spengler, J. R. (2022). Meeting report: 34th international conference on antiviral research. Antiviral Chemistry and Chemotherapy, 30. https://doi.org/10.1177/20402066221130853

@article{01b5eec9e0a9413b913f6e59bca3699f,

title = "Meeting report: 34th international conference on antiviral research",

abstract = "As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.",

keywords = "ICAR, ISAR meeting, Virus, antiviral, therapeutics, vaccines",

author = "Andrea Brancale and Kara Carter and Leen Delang and Jerome Deval and David Durantel and Gentry, {Brian G.} and Robert Jordan and Julander, {Justin G.} and Lo, {Michael K.} and P{\'e}rez-P{\'e}rez, {Maria Jes{\'u}s} and Schang, {Luis M.} and Seley-Radtke, {Katherine L.} and Shi, {Pei Yong} and Vasudevan, {Subhash G.} and Whitley, {Richard J.} and Spengler, {Jessica R.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

doi = "10.1177/20402066221130853",

language = "English (US)",

volume = "30",

journal = "Antiviral Chemistry and Chemotherapy",

issn = "0956-3202",

publisher = "International Medical Press Ltd",

}

TY - JOUR

T1 - Meeting report

T2 - 34th international conference on antiviral research

AU - Brancale, Andrea

AU - Carter, Kara

AU - Delang, Leen

AU - Deval, Jerome

AU - Durantel, David

AU - Gentry, Brian G.

AU - Jordan, Robert

AU - Julander, Justin G.

AU - Lo, Michael K.

AU - Pérez-Pérez, Maria Jesús

AU - Schang, Luis M.

AU - Seley-Radtke, Katherine L.

AU - Shi, Pei Yong

AU - Vasudevan, Subhash G.

AU - Whitley, Richard J.

AU - Spengler, Jessica R.

PY - 2022

Y1 - 2022

N2 - As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.

AB - As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.

KW - ICAR

KW - ISAR meeting

KW - Virus

KW - antiviral

KW - therapeutics

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=85140863683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140863683&partnerID=8YFLogxK

U2 - 10.1177/20402066221130853

DO - 10.1177/20402066221130853

M3 - Article

C2 - 36305015

AN - SCOPUS:85140863683

SN - 0956-3202

VL - 30

JO - Antiviral Chemistry and Chemotherapy

JF - Antiviral Chemistry and Chemotherapy

ER -

Meeting report: 34th international conference on antiviral research

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this